OKYO Pharma (STU:OK10) Gross Margin %: 0.00% (As of Sep. 2025)

OKYO Pharma  (STU:OK10) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

OKYO Pharma had a gross margin of N/A% for the quarter that ended in Sep. 2025 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

OKYO Pharma Gross Margin % Related Terms

The historical data trend for OKYO Pharma's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Gross Margin % Chart

OKYO Pharma Annual Data
	Trend	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25
Gross Margin %		Get a 7-Day Free Trial					0.00	0.00	0.00	0.00	0.00

OKYO Pharma Semi-Annual Data
	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25
Gross Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

STU:OK10 vs ENTX, HRTX, RANI: Gross Margin % Comparison

For the Biotechnology subindustry, OKYO Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OKYO Pharma Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OKYO Pharma's Gross Margin % distribution charts can be found below:

* The bar in red indicates where OKYO Pharma's Gross Margin % falls into.

OKYO Pharma Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

OKYO Pharma's Gross Margin for the fiscal year that ended in Mar. 2025 is calculated as

OKYO Pharma's Gross Margin for the quarter that ended in Sep. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

OKYO Pharma Business Description